ORIGINAL PAPER
DOI: 10.21614/sgo-23-1-64
Surg. Gastroenterol. Oncol. 2018;23(1):642018;23(1):64-70
How Can We Avoid Unnecessary Surgical Resection for Gastric
Subepithelial Tumours? A Multicenter Retrospective Study in Korea
Il Hyun Baek1, Kwang Ro Joo2, and Kyeong Won Min3
Corresponding author:
Il Hyun Baek, M.D., Ph D
Department of Gastroenterology
Eulji University Hospital
Eulji University School of Medicine
1306, Dunsan-dong, Seo-gu
Daejeon, Republic of KOREA 35233
Telephone: +82-42-611-3063
E-mail:drandrea100@daum.net
1
Department of Gastroenterology, Eulji University Hospital, Eulji University School of Medicine
Daejeon, Korea
2
Department of Gastroenterology, Kyung Hee University Hospital at Gangdong
Kyung Hee University, Seoul, Korea
3
Department of Human Resource Development, Graduate School of Chung-Ang University
Seoul, Korea
ABSTRACT
Background: Gastric subepithelial tumors (SETs) are often encountered in endoscopy
without any special symptoms.The effectiveness of current diagnostic tissue sampling
techniques for gastric SETs is limited. Better tissue acquisition methods are required to
improve the diagnostic yield in patients with gastric SETs.The purpose of this study is to
assess the safety and diagnostic effectiveness of an endoscopic incisional target biopsy
technique for gastric SETs.
Methods: This study was intended for patients with gastric SETs with failed tissue diagnosis
by conventional forceps biopsy. Gastric SETs were assessed by endoscopic incisional
target biopsy in order to obtain preoperative pathological diagnosis. Endoscopic ultrasound
(EUS) and abdominal CT, were also part of the assesment, in accordance with diagnostic
management algorithms.
Results: Endoscopic incisional target biopsy provided sufficient tissue specimens for
definite pathologic diagnosis in 17 of 19 cases (diagnostic yield 89.5%). Contrary to widelyheld assumptions, there were so many benign SETs even in over 2 cm sized SET. Only three
out of 19 cases (15.8%) were diagnosed as GIST. In all GISTs, the size of the incisional
target biopsy samples enabled immunohistochemical analysis (100%) and the evaluation of
malignancy risk was performed by measuring the mitotic index in two cases (66.7%). The
mean procedure time for incisional target biopsy was 11.4 ± 5.0 minutes. Six procedurerelated minor bleedings occurred during or after the procedure.
Conclusion: Endoscopic incisional target biopsy appears to be an easy to perform, effective, safe
and less aggressive methods to determine the definitive pathological evaluation and malignant
risk. It can be a reliable alternative to Fine Needle Aspiration (FNA) or (Trucut Biopsy) TCB,
providing larger specimens that improve pathologic yields. To avoid unnecessary surgical
resection of gastric SETs, we recommend tissue diagnosis by endoscopic incisional target biopsy.
Key words: subepithelial tumour, incisional biopsy, stomach
Received: 08.12.2017
Accepted: 25.01.2018
Copyright © Celsius Publishing House
www.sgo-iasgo.com
64
INTRODUCTION
Gastric subepithelial tumours (SETs) with normal overlying mucosa are
frequently encountered during oesophagogastroduodenoscopy (OGD).
Surgery, Gastroenterology and Oncology, 23 (1), 2018
Endoscopic Incisional Target Biopsy
Endoscopic ultrasound (EUS) is used to evaluate the
delineation, echo pattern, size, and layer of origin of SETs
(1,2). Algorithms based on EUS images are instrumental
in determining whether gastric SETs should be monitored or removed endoscopically or surgically (3).
However, it is difficult to offer an exact assessment of
the potential for malignancy by the EUS images alone,
especially in the case of intramural masses with low
echos (4).
Standard endoscopic forceps biopsy, jumbo forceps
biopsy, and bite-on-bite methods generally do not
provide suitable samples for the assessment of gastric
SETs (5). EUS-guided Tru-Cut™ Needle biopsy (EUS-TCB)
and EUS-guided fine-needle aspiration (EUS-FNA) are
now considered standard technique for tissue diagnosis
of gastric SETs. However, the diagnostic accuracy of
EUS-FNA is relatively low, at 62% (6). Although the
EUS-TCB can overcome some of the limitations of the
EUS-FNA, the diagnostic accuracy is less than 60%, due
to its high technical failure rate (7). In other words,
EUS-TCB and EUS-FNA may not be able to provide
enough tissue specimens in order to obtain the
necessary information about immunohistochemistry
(IHC) and the mitotic index, both of which are required
for a detailed histopathological diagnosis of gastric SET.
Therefore, better tissue acquisition methods are
required to ameliorate the diagnostic yield in patients
with gastric SETs. The endoscopic incisional biopsy
technique is used to perform a deep forceps biopsy
after planned incision in order to obtain enough tissue
for histopathological diagnosis. Histopathological
examination will include mitotic counts essential for
the differentiation between potentially malignant
gastrointestinal stromal tumours (GIST) and benign
leiomyomas.
The purpose of this preliminary study is to assess
the safety and diagnostic effectiveness of endoscopic
incisional target biopsy methods for histopathological
diagnosis of gastric SETs.
METHODS
This study was designed to evaluate 19 consecutive gastric SETs patients who had failed histopathological assessment by conventional forceps biopsy.
The ethics committee of Eulji University Hospital
approved the research protocol and received
informed consent from each patient (IRB No. EMC
2016-09-006-002, Clinical trial registration No. KCT
0002306). We retrospectively reviewed procedural
and pathology reports of endoscopic incisional target
biopsy for the evaluation of gastric SETs.
Fig. 1 illustrates the treatment approach strategy for
gastric SETs at our institution. EUS with or without
abdominal CT was initially performed for all gastric
SETs. Conventional EUS (GF UM160; Olympus, Tokyo,
Japan) was performed to assess gastric SETs’ layer of
origin, echogenicity, delineation, shape, location, and
size. Gastric SETs were managed differently depending
on size. Gastric SETs with a diameter less than 1 cm
received EUS six months after the initial inspection, and
then an additional follow-up EUS after twelve months
if volume, echogenicity, or shape did not change
significantly. Gastric SETs of 1~2 cm in diameter under-
Figure 1 - Treatment algorithm for the management of gastric subepithelialtumors. SET, subepithelialtumor;
EUS, endoscopic ultrasound
Surgery, Gastroenterology and Oncology, 23 (1), 2018
65
Il Hyun Baek et al
went incisional biopsy. According to the pathological
diagnosis, SETs were considered for surveillance, endoscopic resection, or surgical resection. Gastric SETs of ≥ 2
cm in diameter underwent incisional biopsy. According
to the pathological diagnosis, SETs were considered for
surveillance or surgical resection.
Experienced endoscopists performed all incisional
biopsies using standard single-channel endoscopes
(GIF-Q260, Olympus Medical Systems Corporation,
Tokyo, Japan). Endoscopic incisional target biopsy was
conducted as follows: (fig. 2), epinephrine in hypertonic
saline solution (10 mL, dilution 1:1000) was injected into
the submucosal layer of the lesion. A 20-30 mm linear
incision using Dual Knife (KD-650 L; Olympus Medical
a
b
c
d
e
Figure 2 - Deep tissue biopsy via endoscopic incisional
target biopsy. (a) A SET was noted at the upper body.
(b) Epinephrine in hypertonic saline solution was
injected into the submucosal layer of the mass. (c) A
linear incision using a dual knife was created over the
highest convexity zone of the lesion. (d) Multiple deep
biopsies were obtained using conventional biopsy
forceps through the incision area. (e) The incision
site was prophylactically closed with endoclips.
66
Surgery, Gastroenterology and Oncology, 23 (1), 2018
Endoscopic Incisional Target Biopsy
Systems Corporation, Tokyo, Japan) and Endocut Q
currents (cut interval 4, cut duration 3, and effect 2) was
achieved at the highest convexity of the lesion while
looking directly at the lesion with an endoscope. Then,
a traditional pair of biopsy forceps (Radial Jaw 4; Boston
Scientific) was inserted deeply and at least five biopsy
samples were obtained. Finally, the incision site was
prophylactically closed with two or three endoclips
(Olympus Medical Systems Corporation, Tokyo, Japan).
Perforation was defined as free air visible on simple
x-ray after procedure. Bleeding was defined as any
oozing or active bleeding requiring endoclipping or
electrocautery during or after the procedure.
Pathological diagnosis included identification of cell
types, cellularity, cytoplasmic features, nuclear atypia,
immunohistochemistry, and mitotic index of sample. The
mitotic index was determined on 50 consecutive
high-power fields (HPF) (8). The characteristics of
mesenchymal origin were determined by conventional
cytological analysis. Immunohistochemical staining was
performed for further differentiation between gastrointestinal stromal tumours and non-gastrointestinal
stromal tumours. With commercially available monoclonal/polyclonal primary antibodies, the most particular
immunohistochemical markers for gastrointestinal
stromal tumours (c-KIT, CD34, smooth muscle actin,
Ki-67, S-100) were analysed.
Statistical analysis
Lesion properties and patient demographics were
analysed using PASW for Windows, version 20.0
(Statistics 20, SPSS, IBM, Armonk, NY). Continuous
variables were expressed as mean ± standard deviation.
Categorical variables were analysed by Chi-square test
and expressed as frequency (%).
RESULTS
During the study period, a total of 19 patients (9
men and 10 women) were included. Mean age was
53.2 years (range 39-64 years). Depending on EUS
assessment, gastric SETs were divided as 14 (73.7%)
small (< 2 cm in diameter) and 5 (26.3%) large (≥ 2 cm)
SETs. SETs were located in the fundus and cardia in 3
cases (15.8%), body of the stomach in 12 cases (63.2%),
and the antrum in 4 cases (21.0%). The degree of
tumour involvement by the SETs was: second layer
(3 patients - 15.8%), third layer (4 patients, 21.0% ), and
fourth layer, respectively ( 12 cases, 63.2% ). In terms of
echogenicity, SETs were either hypoechoic in 16 cases
(84.2%) or mixed in the remaining 3 cases (15.8%).
Clinical, demographic, and endoscopic features of the
Surgery, Gastroenterology and Oncology, 23 (1), 2018
GSETs and patients are summarized in table 1.
Endoscopic incision target biopsy provided sufficient
tissue specimens for definitive pathological diagnosis in
17 of the 19 cases (diagnostic yield rate 89.5%). The
pathological diagnosis was GIST in 3 cases (15.8 %),
leiomyoma in 7 patients (36.8%), heterotopic pancreas in
2 patients (10.5%), glomus tumours (2 cases - 10.5%),
polyps (2 patients - 10.5%), 1 vascular malformation (5.4
%), and 2 not diagnostic (10.5%). Of the 19 patients, 14
(73.7%) were diagnosed with benign gastric SET such
as ectopic pancreas or leiomyoma, and thus an unnecessary operation was avoided. The size of incisional biopsy
samples was sufficient to allow immunohistochemistry in
Table 1 - Endoscopic, demographic, and clinical characteristics
of the patients and lesions
Characteristics
n (%)
Patients, n
Age, average (range), years
19
53.2 (39-64)
Sex, n (%)
Male
9 (47.4)
Female
10 (52.6)
Size of SET on EUS, average(range), n (%)
15.1 (5-30)
< 2 cm
14 (73.7)
≥ 2cm
5 (26.3)
Location, n (%)
Fundus
1 (5.3)
Cardia
2 (10.5)
Body (upper)
10 (52.6)
Body (mid)
1 (5.3)
Body (lower)
1 (5.3)
Antrum
4 (21.0)
Layer, n (%)
2nd
3 (15.8)
3rd
4 (21.0)
4th
12 (63.2)
Echogenicity, n (%)
Hypoechoic
16 (84.2)
Hyperechoic
0 (0.0)
Mixed
3 (15.8)
Pathologic Diagnosis, n (%)
GIST
3 (15.8)
Leiomyoma
7 (36.8)
Heterotopic pancreas
2 (10.5)
Glomus tumour
2 (10.5)
Polyp
2 (10.5)
Vascular malformation
1 (5.4)
Not diagnostic
2 (10.5)
SET, subepithelial tumour; EUS, endoscopic ultrasound;
GIST, gastrointestinal stromal tumour.
67
Il Hyun Baek et al
all (100%) GISTs. Malignant potential was assessed in two
cases (66.7%) by measuring mitotic index (table 2).
The mean procedure time for incisional biopsy was
11.4±5.0 minutes. Six (31.6%) procedure-related minor
bleedings occurred during or after the procedure.
DISCUSSION
Gastric SETs are generally found incidentally during
routine endoscopy. The differential diagnosis of various
types of gastric SETs is important because they can
benefit from different treatment options and also have a
different prognosis. The American Gastroenterological
Association recommends surgical resection of gastric
SETs larger than 3 cm in size with a low or heterogeneous echo originating from the fourth layer.
Conversely, gastric SETs less than 3 cm in size without
the characteristics of malignancy can be evaluated
periodically by EUS (3,9,10). The National Comprehensive
Cancer Network recommends surgical resection for all
GISTs greater than 2 cm in diameter due to malignant
potential, and resection or follow-up for GISTs with a
diameter of less than 2 cm (11). However, even small
GISTs (< 1 cm) have malignant potential and can metastasize to distant organs (12,13). EUS morphological
findings alone cannot replace histopathological diagnosis and cannot accurately predict malignant potential of
gastric subepithelial neoplasms (3, 4). Current management guidelines for gastric subepithelial tumors based
on EUS findings without pathological diagnosis are
likely to lead to unnecessary surgery for benign gastric
SET patients. Therefore, it is essential to obtain appropriate
samples for cytological and immunohistochemical analysis
for the accurate diagnosis and evaluation of potential
malignancy (14-16). EUS-FNA is used to get specimens
from gastric SETs, but its diagnostic yield varies from
38% to 82% (17-19). EUS-FNA has a high incidence of
complications (21.7%), such as bleeding and even one
death after biopsy (20). IHC staining, such as CD117,
CD34, Ki-67, S-100, smooth muscle actin, or desmin, is
important to distinguish SETs. IHC staining is only
possible when a sufficient amount of tissue sample is
available. For this reason, there is a limit to distinguishing
gastric SETs, taking in consideration that the amount of
tissue samples obtained with EUS-FNA is often not
sufficient for IHC staining (21). The reason for the low
diagnosis rate of EUS-FNA is that it is difficult to insert
the needle deeply due to rubbery consistency of
mesenchymal tumour and the stiffness of FNA itself.
Moreover, it is difficult to aspirate the necessary
Table 2 - The results of incisional biopsy for gastric subepithelial tumours
Patient Size, mm
1
Location
20
upper body
2
7
3
15
4
layer echogenicity
Pathologic Dx
Ki-67
mitosis
4th
hypo
Not diagnostic
upper body
4th
hypo
leiomyoma
upper body
3rd
hypo
glomus tumour
30
mid body
3rd
mixed
heterotopic pancreas
5
5
lower body
4th
hypo
Not diagnostic
6
20
cardia
4th
hypo
leiomyoma
7
12
antrum
2nd
hypo
hamartomatous polyp
8
12
upper body
4th
hypo
glomus tumour
9
12
fundus
2nd
hypo
fibroid polyp
10
17
antrum
4th
hypo
GIST
< 1%
0~1/50 HPF
11
10
cardia
4th
hypo
GIST
< 1%
0~1/50 HPF
12
20
antrum
4th
hypo
leiomyoma
< 1%
13
15
upper body
2nd
hypo
leiomyoma
< 2%
14
17
upper body
4th
hypo
GIST
< 1%
15
15
upper body
4th
hypo
leiomyoma
16
12
upper body
3rd
mixed
vascular malformation
17
15
upper body
4th
hypo
leiomyoma
18
20
antrum
3rd
mixed
heterotopic pancreas
19
15
upper body
4th
hypo
leiomyoma
< 1%
EUS, endoscopic ultrasound; hypo, hypoechoic; hyper, hyperechoic; mixed, mixed echogenicity;
GIST, gastrointestinal stromal tumour. IHC (immunohistochemistry)
68
Surgery, Gastroenterology and Oncology, 23 (1), 2018
Endoscopic Incisional Target Biopsy
amount of cells because a small gauge needle is used.
EUS-guided TCB (trucut biopsy), designed to overcome
these problems, has been able to obtain a larger tissue
specimen that retains the morphology of the tissue,
enabling more accurate histological diagnosis than
cytological diagnosis. However, even in recent studies,
the diagnostic yield of TCB in gastric SETs is moderate
(47% -63%) and is not superior to EUS-FNA (6,7,22).
This is because it is difficult to aim and penetrate small
gastric SETs covered with normal elastic mucosa. Also,
a straight and stiff needle cannot pass through the
channel of the bended endoscope to aim lesions in
difficult-to-reach areas such as gastric cardia or fundus
and duodenum (7, 11). When assessing the malignancy
potential of GIST, information about the mitotic index
of the tumour is important. Nevertheless, the EUS-TCB
tissue specimen is too small to reliably provide information about the mitotic index to determine the malignant potential of gastric stromal tumours (14,22). There
are also concerns about safety. Of the 52 procedures
performed for gastric SETs, there were 2 cases of sepsis
(22). Also, there is a risk of malignant cells spreading
into the abdominal cavity after the lesion was
punctured (23). Although endoscopic partial resection
(the "unroofing" technique) has been advocated as an
efficient measure, preliminary studies have shown that
the risk of haemorrhage following endoscopic snare
resection was as high as 56%, despite providing
sufficient tissue specimens for mitotic analysis (21).
There are also technical restrictions, because it is
difficult to snare the skiddy lesion when gastric the SET
is of rubbery consistency or grows extraluminallly.
Therefore, a breakthrough EUS-based tissue acquisition
methods such as the endoscopic incisional target
biopsy technique used in this study is needed. 17
(diagnostic yield 89.5%) out of 19 of our patients, who
underwent endoscopic incisional target biopsy, had
enough tissue samples for definite pathologic diagnosis,
immunohistochemical analysis, and mitotic index of
GISTs. In this study, endoscopic incisional target biopsy
shows some advantages over the EUS-FNA or EUS-TCB,
providing sufficiently large tissue specimens for final
diagnosis in a cost-effective manner, reducing unnecessary surgical resection due to insufficient specimens or
avoiding needless follow-up study. In addition, endoscopic incisional target biopsy can be made easier and
safer regardless of the location of the gastric SET. Since
conventional biopsy forceps are used to perform
biopsy while looking directly at the lesion, there were
less bleeding complications in comparison to other
invasive methods. That has to do with the fact that
frank bleeding or exposed blood vessels can be
Surgery, Gastroenterology and Oncology, 23 (1), 2018
immediately treated during the procedure. Moreover,
delayed hemorrhage was also prevented by clipping of
the incised mucosa as a prophylactic manoeuvre. In this
study, six (31.6%) procedure-related minor bleedings
occurred during or after the procedure. However, there
was no infection or perforation related morbidity during
or after incisional biopsy.
This study has some limitations, such as its retrospective nature, small sample size, and also the fact that
it has not been directly compared to other methods
such as conventional or EUS-TCB or EUS-FNA. Further
studies involving more patients are required to compare
endoscopic incisional target biopsy with other tissue
sampling methods.
CONCLUSIONS
In conclusion, endoscopic incisional target biopsy
seems to be a safe, simple, effective and less aggressive
methods for the assessment of potential malignancy
and establishment of a management plan for gastric
subepithelial tumours. It can be a dependable
substitute to traditional TCB and FNA, providing a larger
specimen that improves pathologic yields. Contrary to
widely-held assumptions, there are numerous benign
SETs even in over 2cm sized SET. In order to avoid
unnecessary surgical resection, we recommend decisive
tissue diagnosis by endoscopic incisional target biopsy in
gastric SETs.
Conflict of interest
The authors declare that there is no conflict of
interest.
REFERENCES
1.
2.
3.
4.
5.
6.
Rösch T. Endoscopic ultrasonography in upper gastrointestinal submucosal tumors: a literature review. Gastrointest Endosc Clin N Am.
1995;5(3):609-14.
Caletti G, Deviere J, Fockens P, Lees WR, Mortensen B, Odegaard S,
et al. Guidelines of the European Society of Gastrointestinal
Endoscopy (ESGE) Part II: Retroperitoneum and large bowel,
training. The European Endosonography Club Working Party.
Endoscopy. 1996;28(7):626-8.
Hwang JH1, Rulyak SD, Kimmey MB. American Gastroenterological
Association Institute technical review on the management of gastric
subepithelial masses. Gastroenterology. 2006;130(7):2217-28.
Hwang JH, Saunders MD, Rulyak SJ, Shaw S, Nietsch H, Kimmey
MB. A prospective study comparing endoscopy and EUS in the
evaluation of GI subepithelial masses. Gastrointest Endosc. 2005;
62(2):202-8.
Cantor MJ, Davila RE, Faigel DO. Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps
biopsies and endoscopic submucosal resection. Gastrointest
Endosc. 2006;64(1):29-34.
Hoda KM, Rodriguez SA, Faigel DO. EUS-guided sampling of
suspected GI stromal tumors. Gastrointest Endosc. 2009;69(7):
1218-23. doi: 10.1016/j.gie.2008.09.045. Epub 2009 Apr 25.
69
Il Hyun Baek et al
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
70
Fernández-Esparrach G, Sendino O, Solé M, Pellisé M, Colomo L,
Pardo A, et al. Endoscopic ultrasound-guided fine-needle aspiration
and trucut biopsy in the diagnosis of gastric stromal tumors: a
randomized crossover study. Endoscopy. 2010;42(4):292-9. doi:
10.1055/s-0029-1244074. Epub 2010 Mar 30.
Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ,
et al. Diagnosis of gastrointestinal stromal tumors: A consensus
approach. Hum Pathol. 2002;33(5):459-65.
Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL, et al.
Endosonographic differentiation of benign and malignant stromal
cell tumors. Gastrointest Endosc. 1997;45(6):468-73.
Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP.
Endosonographic features predictive of benign and malignant
gastrointestinal stromal cell tumours. Gut. 2000;46(1):88-92.
Kim MY, Jung HY, Choi KD, Song HJ, Lee JH, Kim DH, et al. Natural
history of asymptomatic small gastric subepithelial tumors. J Clin
Gastroenterol. 2011;45(4):330-6.
Meesters B, Pauwels PA, Pijnenburg AM, Vlasveld LT, Repelaer van
Driel OJ. Metastasis in a benign duodenal stromal tumour. Eur J
Surg Oncol. 1998;24(4):334-5.
Trupiano JK, Stewart RE, Misick C, Appelman HD, Goldblum JR.
Gastric stromal tumors: a clinicopathologic study of 77 cases with
correlation of features with nonaggressive and aggressive clinical
behaviors. Am J Surg Pathol. 2002;26(6):705-14.
Polkowski M, Bergman JG. Endoscopic ultrasonography-guided
biopsy for submucosal tumors: needless needling? Endoscopy.
2010;42(4):324-6. doi: 10.1055/s-0029-1244070. Epub 2010 Mar
30.
Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY; ESMO
Guidelines Working Group. Gastrointestinal stromal tumours: ESMO
clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2009;20 Suppl 4:64-7. doi: 10.1093/annonc/mdp131.
Philipper M, Hollerbach S, Gabbert HE, Heikaus S, Böcking A,
Pomjanski N, et al. Prospective comparison of endoscopic ultra-
17.
18.
19.
20.
21.
22.
23.
sound-guided fine-needle aspiration and surgical histology in upper
gastrointestinal submucosal tumors. Endoscopy. 2010;42(4):300-5.
doi: 10.1055/s-0029-1244006. Epub 2010 Mar 19.
Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb
J, et al. Endoscopic ultrasound guided fine needle aspiration biopsy:
a large single centre experience. Gut. 1999;44(5):720-6.
Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasoundguided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol. 2001;25(6):34350.
Akahoshi K, Sumida Y, Matsui N, Oya M, Akinaga R, Kubokawa M,
et al. Preoperative diagnosis of gastrointestinal stromal tumor by
endoscopic ultrasound-guided fine needle aspiration. World J
Gastroenterol. 2007;13(14):2077-82.
Eckardt AJ, Adler A, Gomes EM, Jenssen C, Siebert C, Gottschalk U,
et al. Endosonographic large-bore biopsy of gastric subepithelial
tumors: a prospective multicenter study. Eur J Gastroenterol Hepatol.
2012;24(10):1135-44.
Lee CK, Chung IK, Lee SH, Lee SH, Lee TH, Park SH, et al.
Endoscopic partial resection with the unroofing technique for
reliable tissue diagnosis of upper GI subepithelial tumors originating
from the muscularis propria on EUS (with video). Gastrointest
Endosc. 2010;71(1):188-94. doi: 10.1016/j.gie.2009.07.029. Epub
2009 Oct 30.
Polkowski M, Gerke W, Jarosz D, Nasierowska-Guttmejer A,
Rutkowski P, Nowecki ZI, et al. Diagnostic yield and safety of endoscopic ultrasound-guided trucut [corrected] biopsy in patients with
gastric submucosal tumors: a prospective study. Endoscopy.
2009;41(4):329-34. doi: 10.1055/s-0029-1214447. Epub 2009 Apr 1.
Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Wozniak A,
Limon J, et al. Risk criteria and prognostic factors for predicting
recurrences after resection of primary gastrointestinal stromal
tumor. Ann Surg Oncol. 2007;14(7):2018-27. Epub 2007 May 2.
Surgery, Gastroenterology and Oncology, 23 (1), 2018